News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
O'Neil Thomas P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 13,877 shares
@ $0.91, valued at
$12.6k
Disposed/sold 60,000 options to buy
@ $29, valued at
$1.7M
Disposed/sold 80,000 options to buy
@ $4.6, valued at
$368k
Disposed/sold 190,000 options to buy
@ $3.46, valued at
$657.4k
Disposed/sold 72,340 options to buy
@ $4.56, valued at
$329.9k
Disposed/sold 76,595 options to buy
@ $1.04, valued at
$79.7k
|
|
| 06/07/2022 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 190,000 options to buy
@ $3.46, valued at
$657.4k
|
|
| 12/07/2020 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Granted 80,000 options to buy
@ $4.6, valued at
$368k
|
|
| 09/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Sold 1,000 shares
@ $25.3235, valued at
$25.3k
Exercised 1,000 options to buy
@ $4.56, valued at
$4.6k
|
|
| 05/21/2020 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Sold 2,000 shares
@ $25, valued at
$50k
Exercised 2,000 options to buy
@ $4.56, valued at
$9.1k
|
|
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/17/2018 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 21,100 shares
@ $0
Granted 14,050 options to buy
@ $8.58, valued at
$120.5k
|
|
| 03/02/2018 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 6,000 shares
@ $0
Granted 34,000 options to buy
@ $16.95, valued at
$576.3k
|
|
| 12/20/2017 |
4
| O'Neil Thomas P. (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Sold 8,000 shares
@ $20, valued at
$160k
Exercised 4,000 options to buy
@ $1.16, valued at
$4.6k
Exercised 4,000 options to buy
@ $4.21, valued at
$16.8k
|
|
| 10/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/10/2016 |
3
| O'Neil Thomas P. (CFO) has filed a Form 3 on Protagonist Therapeutics, Inc |
|
|